Sterile bispecific monoclonal antibody formulation administered intravenously in oncology protocols. Supplied by pharmaceutical manufacturers to hospitals and specialized cancer treatment facilities. Procured by healthcare procurement teams for use in hematologic malignancy therapies by oncologists and infusion centers.